Global Self-monitoring Blood Glucose Devices Market 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Global Self-monitoring Blood Glucose Devices Market 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Market Highlights

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on theGlobal Self-monitoring Blood

Glucose Devices Market 2015-2019,

please mail us atenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “An increase in the aging population is expected to boost the growth of the global SMBG devices market. According to WHO, more than 22% of the world population will be above 65 years of age by 2030. The aging population is more susceptible to chronic diseases such as diabetes and other metabolic disorders.”

• Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment.

• Technavio's analysts forecast the global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Global Self-monitoring Blood Glucose Devices Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and for a full list of vendors view our

report:

Global Self-monitoring Blood Glucose Devices Market 2015-2019

Abbott Diagnostics

Bayer Healthcare

LifeScan

Abbott Diagnostics was founded in 1972 and is headquartered in Lake Forest, Illinois, US. It offers in vitro diagnostics and a wide range of instrument systems and tests for hospitals, reference labs, physician offices, blood banks, and clinics.

Bayer HealthCare was incorporated in1863 and is headquartered in Leverkusen, Germany. It operates as a subsidiary of Bayer, a pharmaceuticals and chemical industry. Bayer HealthCare focuses on R&D, manufacturing, and sales of drugs, pharmaceuticals, vaccines, antibiotics, and small components for human and animal health worldwide.

LifeScan was founded in 1986 and is headquartered in Chesterbrook, Pennsylvania, US. The company manufactures and markets blood glucose monitoring systems for home and hospital use. It is a subsidiary of Johnson & Johnson.

USA – CANADA – UK – CHINA – INDIA

Market Landscape• The global SMBG devices market is an organized market and has opportunities for rapid

growth due to the rising incidence of diabetes worldwide.

• Apart from portability and safety, SMBG devices offer accuracy and can operate with low power consumption.

• The US, with the world’s highest per capita healthcare expenditure and dominated the market in 2014.

• The market in EMEA is also expected to see a steady growth rate because of the rise in point-of-care testing (POCT) instruments and the emergence of new technologies in diagnostics devices during the forecast period.

• The market is established with the presence of both leading and emerging companies. Among the leading companies, Abbott Diagnostics, Bayer Healthcare, LifeScan, and Roche Diagnostics held the major market share in 2014.

• Vendors are investing in R&D for designing and developing innovative SMBG devices that can give accurate results.

USA – CANADA – UK – CHINA – INDIA

Key Market HighlightsGuest Bloggers

• Authenticity • Delivery • Price• Service

Support

• There is intense competition among vendors in terms of pricing, which has resulted in low-profit margins.

• The stiff competition among vendors in the market is largely based on the design and manufacturing cost of the product.

• Local vendors offer products at a lower price compared to global players, which allows customers to choose from a wide variety of products.

• In addition, customers from developing countries have low awareness of new products and low purchasing power.

• They prefer local companies that provide better after-sales support, which compels multinational companies to scale down their product prices.

• Roche Diagnostics and LifeScan have lost more than 3% of their market share in the last three years.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Global Self-monitoring Blood Glucose Devices

Market 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North AmericaChicago, USA

Phone: +1 630 333 9501  Fax: +1 630 833 2171

EuropeLondon, United

Kingdom Phone: +44 208 123 1770

Fax: +44 845 280 2825

AsiaBangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION